Literature DB >> 25074731

The origin of regional failure in oral cavity squamous cell carcinoma with pathologically negative neck metastases.

Moran Amit1, Tzu Chen Yen2, Chun Ta Liao2, Pankaj Chaturvedi3, Jai Prakash Agarwal3, Luiz Paulo Kowalski4, Hugo F Kohler4, Ardalan Ebrahimi5, Jonathan R Clark6, Claudio Roberto Cernea7, Jose S Brandao7, Matthias Kreppel8, Joachim E Zöller8, Leonor Leider-Trejo9, Gideon Bachar10, Thomas Shpitzer10, Andrea Villaret Bolzoni11, Raj P Patel12, Sashikanth Jonnalagadda13, Thomas Kevin Robbins14, Jatin P Shah13, Snehal G Patel14, Ziv Gil1.   

Abstract

IMPORTANCE: Squamous cell carcinoma of the oral cavity (OSCC) is a common malignant tumor worldwide.
OBJECTIVE: To determine if regional failure in patients with OSCC and pathologically negative neck nodes (pN-) is due to an incomplete sampling procedure during surgery. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively reviewed the medical records of 2258 patients from 11 cancer centers worldwide who underwent neck dissection for OSCC (1990-2011) and who were pN-. Of those, 345 had clinical evidence of nodal metastases (cN+) on radiologic workup. The neck specimens were available for reanalysis in 193 patients. Survival rates were calculated using the Kaplan-Meier graphs and analyzed by multivariable analysis. MAIN OUTCOMES AND MEASURES: Five-year overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS).
RESULTS: Resectioning and analysis of the neck dissection specimens in the cN+/pN- subgroup revealed false-negative results in 29 (15%) of 193 patients. The negative predictive value of the initial pathologic examination was 85%. The 5-year OS and DSS in the cN-/pN- group were 77.6% and 87.2%, respectively. The 5-year OS and DSS of the cN+/pN- group were 62.6% and 78.5%, respectively (P < .001). In multivariable analysis, cN+ classification was significantly associated with poor OS (hazard ratio [HR], 1.7; 95% CI, 1.1-3.8; P = .03) and poor DSS (HR, 1.46; 95% CI, 1.1-4.1; P = .04). A cN+ classification was associated with lower DFS (66.3% vs 76.2%; P = .05) and lower regional recurrence-free survival (68.6% vs 78.8%; P = .02) but not with local (P = .20) or distant recurrence (P = .80). CONCLUSIONS AND RELEVANCE: Pathologic staging underestimates the incidence of nodal metastases in cN+ disease. After correction for pathologically missed nodal metastases, radiologic evidence of neck nodes is an independent predictor of outcome, suggesting that traditional sampling during surgery might miss metastases, and this fact might explain the origin of treatment failure in these patients.

Entities:  

Mesh:

Year:  2014        PMID: 25074731     DOI: 10.1001/jamaoto.2014.1539

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  6 in total

1.  The origin of failure, and an opportunity to learn.

Authors:  Balazs B Lörincz
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-10       Impact factor: 2.503

Review 2.  Mechanism of tumour microenvironment in the progression and development of oral cancer.

Authors:  Mohd Mughees; Anindita Sengupta; Sapna Khowal; Saima Wajid
Journal:  Mol Biol Rep       Date:  2021-01-25       Impact factor: 2.316

3.  Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study.

Authors:  Moran Amit; Shorook Na'ara; Leonor Trejo-Leider; Naomi Ramer; David Burstein; Ma Yue; Brett Miles; Xinjie Yang; Delin Lei; Kristine Bjoerndal; Christian Godballe; Thomas Mücke; Klaus-Dietrich Wolff; André M Eckardt; Chiara Copelli; Enrico Sesenna; Snehal Patel; Ian Ganly; Ziv Gil
Journal:  Head Neck       Date:  2017-03-02       Impact factor: 3.147

4.  Diplopia: a unique presentation of recurrence of a salivary gland carcinoma.

Authors:  David Mackinlay; Aaron Stephen James Ferguson; Sharon White; Jaiganesh Manickavasagam
Journal:  BMJ Case Rep       Date:  2019-05-05

5.  The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study.

Authors:  Eran Fridman; Shorook Na'ara; Jaiprakash Agarwal; Moran Amit; Gideon Bachar; Andrea Bolzoni Villaret; Jose Brandao; Claudio R Cernea; Pankaj Chaturvedi; Jonathan Clark; Ardalan Ebrahimi; Dan M Fliss; Sashikanth Jonnalagadda; Hugo F Kohler; Luiz P Kowalski; Matthias Kreppel; Chun-Ta Liao; Snehal G Patel; Rajan S Patel; K Thomas Robbins; Jatin P Shah; Thomas Shpitzer; Tzu-Chen Yen; Joachim E Zöller; Ziv Gil
Journal:  Cancer       Date:  2018-05-14       Impact factor: 6.860

6.  BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.

Authors:  Xue Wang; Chunyu Wang; Guangqi Yan; Yuanyuan Kang; Ge Sun; Shengli Wang; Renlong Zou; Hongmiao Sun; Kai Zeng; Huijuan Song; Wei Liu; Ning Sun; Wensu Liu; Yue Zhao
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.